08/21/2025
6:07 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2025
4:28 PM | ARROWHEAD PHARMACEUTICALS, INC. (Subject)
Sarepta Therapeutics (Filed by)
| Form SCHEDULE 13D/A | |
08/13/2025
7:55 PM | ARROWHEAD PHARMACEUTICALS, INC. (Subject)
Sarepta Therapeutics (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2025
11:49 AM | Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/06/2025
7:02 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
7:03 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2025
7:01 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2025
7:00 PM | Sarepta Therapeutics (Issuer)
Wong Ryan Ho-Yan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2025
7:10 PM | Sarepta Therapeutics (Issuer)
Wong Ryan Ho-Yan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2025
7:14 PM | D. E. SHAW & CO, L.P. (Filed by)
Sarepta Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/21/2025
6:30 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for SRPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sarepta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/16/2025
3:11 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:30 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
6:32 AM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
6:00 AM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
3:15 PM | Sarepta Therapeutics (Filer)
| Form ARS | |
03/13/2025
7:00 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
4:33 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
03/04/2025
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:05 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:32 PM | Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:38 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
7:00 PM | Murray Dallan (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
7:30 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
11:25 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:06 PM | Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:18 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
7:15 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:00 PM | Rothfuss Cristin (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
6:17 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:40 AM | JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
9:27 AM | Capital International Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
09/16/2024
7:00 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2024
7:05 PM | Connelly Deirdre P (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:51 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
4:03 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access